vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Mayville Engineering Company, Inc. (MEC). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $134.3M, roughly 2.0× Mayville Engineering Company, Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs -3.2%, a 18.1% gap on every dollar of revenue. On growth, Mayville Engineering Company, Inc. posted the faster year-over-year revenue change (10.7% vs 9.8%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs -8.8%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Mayville Engineering Company, Inc. is a U.S.-headquartered leading manufacturer of metal components, fabricated assemblies, and custom engineered solutions. It serves OEM clients across agriculture, construction, transportation, defense, and power sports markets, offering end-to-end services from prototyping to high-volume production for North America.
BCPC vs MEC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $134.3M |
| Net Profit | $39.2M | $-4.4M |
| Gross Margin | 35.6% | 6.8% |
| Operating Margin | 19.8% | -4.1% |
| Net Margin | 14.9% | -3.2% |
| Revenue YoY | 9.8% | 10.7% |
| Net Profit YoY | 16.8% | -127.3% |
| EPS (diluted) | $1.21 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $134.3M | ||
| Q3 25 | $267.6M | $144.3M | ||
| Q2 25 | $255.5M | $132.3M | ||
| Q1 25 | $250.5M | $135.6M | ||
| Q4 24 | $240.0M | $121.3M | ||
| Q3 24 | $239.9M | $135.4M | ||
| Q2 24 | $234.1M | $163.6M | ||
| Q1 24 | $239.7M | $161.3M |
| Q4 25 | $39.2M | $-4.4M | ||
| Q3 25 | $40.3M | $-2.7M | ||
| Q2 25 | $38.3M | $-1.1M | ||
| Q1 25 | $37.1M | $20.0K | ||
| Q4 24 | $33.6M | $16.0M | ||
| Q3 24 | $33.8M | $3.0M | ||
| Q2 24 | $32.1M | $3.8M | ||
| Q1 24 | $29.0M | $3.2M |
| Q4 25 | 35.6% | 6.8% | ||
| Q3 25 | 35.7% | 11.0% | ||
| Q2 25 | 36.4% | 10.3% | ||
| Q1 25 | 35.2% | 11.3% | ||
| Q4 24 | 36.0% | 8.9% | ||
| Q3 24 | 35.6% | 12.6% | ||
| Q2 24 | 35.5% | 13.6% | ||
| Q1 24 | 34.0% | 13.0% |
| Q4 25 | 19.8% | -4.1% | ||
| Q3 25 | 20.4% | 0.0% | ||
| Q2 25 | 20.1% | 0.1% | ||
| Q1 25 | 20.4% | 1.2% | ||
| Q4 24 | 19.8% | 19.0% | ||
| Q3 24 | 20.0% | 4.2% | ||
| Q2 24 | 19.6% | 5.0% | ||
| Q1 24 | 17.4% | 4.7% |
| Q4 25 | 14.9% | -3.2% | ||
| Q3 25 | 15.1% | -1.9% | ||
| Q2 25 | 15.0% | -0.8% | ||
| Q1 25 | 14.8% | 0.0% | ||
| Q4 24 | 14.0% | 13.2% | ||
| Q3 24 | 14.1% | 2.2% | ||
| Q2 24 | 13.7% | 2.3% | ||
| Q1 24 | 12.1% | 2.0% |
| Q4 25 | $1.21 | $-0.22 | ||
| Q3 25 | $1.24 | $-0.13 | ||
| Q2 25 | $1.17 | $-0.05 | ||
| Q1 25 | $1.13 | $0.00 | ||
| Q4 24 | $1.03 | $0.76 | ||
| Q3 24 | $1.03 | $0.14 | ||
| Q2 24 | $0.98 | $0.18 | ||
| Q1 24 | $0.89 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $1.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $240.7M |
| Total Assets | $1.7B | $563.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $1.5M | ||
| Q3 25 | $65.1M | $1.2M | ||
| Q2 25 | $65.4M | $206.0K | ||
| Q1 25 | $49.9M | $183.0K | ||
| Q4 24 | $49.5M | $206.0K | ||
| Q3 24 | $73.7M | $178.0K | ||
| Q2 24 | $63.7M | $314.0K | ||
| Q1 24 | $60.3M | $314.0K |
| Q4 25 | $1.3B | $240.7M | ||
| Q3 25 | $1.3B | $244.8M | ||
| Q2 25 | $1.3B | $246.8M | ||
| Q1 25 | $1.2B | $250.0M | ||
| Q4 24 | $1.1B | $251.8M | ||
| Q3 24 | $1.2B | $238.4M | ||
| Q2 24 | $1.1B | $238.1M | ||
| Q1 24 | $1.1B | $234.0M |
| Q4 25 | $1.7B | $563.6M | ||
| Q3 25 | $1.7B | $585.6M | ||
| Q2 25 | $1.7B | $433.7M | ||
| Q1 25 | $1.6B | $447.7M | ||
| Q4 24 | $1.6B | $445.6M | ||
| Q3 24 | $1.6B | $466.0M | ||
| Q2 24 | $1.6B | $488.2M | ||
| Q1 24 | $1.6B | $499.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $13.4M |
| Free Cash FlowOCF − Capex | — | $10.2M |
| FCF MarginFCF / Revenue | — | 7.6% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $26.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $13.4M | ||
| Q3 25 | $65.6M | $1.9M | ||
| Q2 25 | $47.3M | $15.0M | ||
| Q1 25 | $36.5M | $8.3M | ||
| Q4 24 | $52.3M | $38.0M | ||
| Q3 24 | $51.3M | $17.9M | ||
| Q2 24 | $45.0M | $23.3M | ||
| Q1 24 | $33.4M | $10.6M |
| Q4 25 | — | $10.2M | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $35.6M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $19.2M | ||
| Q1 24 | — | $7.8M |
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | -0.8% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 29.4% | ||
| Q3 24 | — | 11.1% | ||
| Q2 24 | — | 11.7% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 1.7% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | 416.65× | ||
| Q4 24 | 1.56× | 2.38× | ||
| Q3 24 | 1.52× | 6.03× | ||
| Q2 24 | 1.40× | 6.15× | ||
| Q1 24 | 1.15× | 3.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
MEC
| Fabrication | $72.2M | 54% |
| Construction And Access | $19.2M | 14% |
| Tubes | $16.2M | 12% |
| Other Market | $11.9M | 9% |
| Agriculture | $7.7M | 6% |
| Military | $6.7M | 5% |
| Outdoor Sports | $1.7M | 1% |
